Biovie (BIVI) Assets (2013 - 2026)
Biovie (BIVI) posted Assets of $17.5 million for Q1 2026, down 22.17% sequentially from $22.5 million in Q4 2025, and down 28.98% YoY from $24.7 million in Q1 2025.
Biovie (BIVI) Assets (2013 - 2026) Analysis & Trends
Biovie has reported Assets for 14 years, with the latest figure at $17.5 million in Q1 2026.
- Quarterly Assets fell 28.98% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (down 28.98% YoY) and the FY2025 annual result came in at $21.6 million, down 14.46% from the prior year.
- Assets retreated to $17.5 million in Q1 2026 per BIVI's latest filing, from $22.5 million in the prior quarter.
- Over five years, Assets peaked at $47.2 million in Q4 2022 and troughed at $17.5 million in Q1 2026.
- A 5-year average of $27.0 million and a median of $24.7 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets soared 232.65% in 2022, then tumbled 54.46% in 2023.
- Over 5 years, Assets stood at $47.2 million in 2022, then sank by 54.46% to $21.5 million in 2023, then grew by 19.56% to $25.7 million in 2024, then dropped by 12.42% to $22.5 million in 2025, then dropped by 22.17% to $17.5 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $17.5 million, $22.5 million, and $26.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | 14.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 17.51 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 26.82 Mn |
| Jun 30, 2025 | 21.56 Mn |
| Mar 31, 2025 | 24.66 Mn |
| Dec 31, 2024 | 25.69 Mn |
| Sep 30, 2024 | 21.24 Mn |
| Jun 30, 2024 | 25.21 Mn |
| Mar 31, 2024 | 31.77 Mn |
| Dec 31, 2023 | 21.49 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 35.10 Mn |
| Mar 31, 2023 | 45.18 Mn |
| Dec 31, 2022 | 47.19 Mn |
| Sep 30, 2022 | 22.86 Mn |
| Jun 30, 2022 | 20.11 Mn |
| Mar 31, 2022 | 26.19 Mn |
| Dec 31, 2021 | 31.87 Mn |
| Sep 30, 2021 | 21.98 Mn |